APOLLOHOSP

Apollo Hospitals Enterprise Share Price

₹6,720.65 +33.75 (0.5%)

21 Nov, 2024 14:21

SIP TrendupStart SIP in APOLLOHOSP

Start SIP

Performance

  • Low
  • ₹6,594
  • High
  • ₹6,733
  • 52 Week Low
  • ₹5,285
  • 52 Week High
  • ₹7,545
  • Open Price₹6,624
  • Previous Close₹6,687
  • Volume148,252

Investment Returns

  • Over 1 Month -3.8%
  • Over 3 Month + 0.67%
  • Over 6 Month + 12.83%
  • Over 1 Year + 22.72%
SIP Lightning

Smart Investing Starts Here Start SIP with Apollo Hospitals Enterprise for Steady Growth!

Invest Now

Apollo Hospitals Enterprise Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 81.7
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 96,633
  • P/B Ratio
  • 13.2
  • Average True Range
  • 178.84
  • EPS
  • 82.28
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 8.03
  • RSI
  • 36.71
  • MFI
  • 66.06

Apollo Hospitals Enterprise Financials

Apollo Hospitals Enterprise Technicals

EMA & SMA

Current Price
₹6,720.65
+ 33.75 (0.5%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹6,970.63
  • 50 Day
  • ₹6,942.99
  • 100 Day
  • ₹6,785.19
  • 200 Day
  • ₹6,465.42

Resistance and Support

6715 Pivot Speed
  • R3 6,904.50
  • R2 6,850.70
  • R1 6,768.80
  • S1 6,633.10
  • S2 6,579.30
  • S3 6,497.40

What's your outlook on Apollo Hospitals Enterprise?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Apollo Hospitals, is India's leading healthcare provider, renowned for pioneering private healthcare. With a vast network of hospitals, clinics, and pharmacies, Apollo is recognized for clinical excellence and innovative medical technologies.

Apollo Hosps.Enterprise has an operating revenue of Rs. 20,469.40 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 7% is okay, ROE of 12% is good. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -8% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 52 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Apollo Hospitals Enterprise Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-06 Quarterly Results
2024-08-13 Quarterly Results
2024-08-03 ESOP
2024-05-30 Audited Results & Final Dividend
2024-02-08 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-08-17 FINAL Rs.10.00 per share(200%)Final Dividend
2024-02-20 INTERIM Rs.6.00 per share(120%)Interim Dividend
2023-08-19 FINAL Rs.9.00 per share(180%)Final Dividend
2023-02-24 FINAL Rs.6.00 per share(120%)Interim Dividend

Apollo Hospitals Enterprise F&O

Apollo Hospitals Enterprise Shareholding Pattern

29.33%
12.8%
5.9%
45.37%
0.11%
3.62%
2.87%

About Apollo Hospitals Enterprise

Company Brief

Widely known for operating a nationwide legendary chain of hospitals, the Apollo group is a modern healthcare giant that also runs several diagnostic centres, pharmacies and telehealth clinics under its umbrella. Over the years, the group has forayed into other non-core healthcare domains like health insurance, medical colleges and medvarsity, nursing and hospital management, global projects consultancy and research. 
The prominent brands under its roof include Apollo Munich Health Insurance, Apollo Pharmacy, Life Studio, Apollo Spectra, and Apollo Cradle, besides Apollo Clinic and Hospitals.

Apollo Hospitals was founded by Dr Prathap C Reddy, with its first-ever branch established in Chennai in 1983 and inaugurated by the then president Shri Giani Zail Singh. In the 1980's it had declared its maiden dividend of 10% and established a branch in Hyderabad. Since then, it has set up numerous branches in New Delhi, Bangalore, Kolkata, Mumbai, Noida, Ahmedabad, and Bhubaneshwar, among other Indian cities. It also has a branch in Dhaka, Bangladesh.
One of its early trailblazing endeavours was telemedicine services in 2000 at Aragonda village in Chittoor, Andhra Pradesh. In 2012, 38% stake of the group's healthcare BPO segment was disposed off to Sutherland Global Services at a valuation of INR 225 crores. Further, in early 2020, the majority stake of its insurance subsidiary Apollo Munich Health Insurance was acquired by HDFC for INR 1,495.81 crores.
Over the years, the group has earned multiple international recognitions in healthcare standards, biotechnological breakthroughs and innovative medical care. It has 8 JCIA and 30 NABH (National Accreditation Board for Hospitals) accredited hospitals, not to mention its state-of-the-art speciality wings, including 25 Heart institutes, several cancer hospitals and organ transplant centres.

Board, Management and Auditors

Board of Directors

The board of directors manages the group in the parent company under the able leadership of founder chairman Dr Prathap Chandra Reddy - a Padma Bhushan and Padma Vibhushan awardee. The board consists of:

Executive Director - Prathap C. Reddy 

Dr Reddy is the visionary founder of the Apollo enterprise, responsible for ushering in an era of world-class medical facilities and treatments in India. He is the torchbearer of modern healthcare in this country and is the driving force behind the group's success.

Executive Vice Chairperson - Dr Preetha Reddy

A member of the founding family Dr Reddy is known for her immense contribution to the furtherance of the Apollo group and the betterment of the country through her philanthropic ventures and able governance.

 Executive Vice Chairperson - Ms Shobana Kamineni

Another member of the founding family has advocated the operation of integrated digital-first healthcare services in the country through Apollo 24/7. Presently Ms Kamineni leads the country's largest pharmacy chain, Apollo Pharmacy, with a countrywide network of over 4,000+ stores and 30,000+ employees.

Ms Suneeta Reddy -  Managing Director

Ms Reddy is at the forefront of the group's finance and strategy functions and serves on various subsidiaries' boards.

Dr Sangita Reddy- Joint Managing Director

As a joint MD, Dr Reddy spearheads the Global Healthcare service delivery and is an honourable member of the World Economic Forum.

Independent Directors

M B N Rao is the lead independent director, and Vinayak Chatterjee, Murali Doraiswamy, V Kavitha Dutt, and Som Mittal are eminent independent directors on the board who oversee the corporate governance of the company and look into the interest of the investors and public.

Auditors

The financials are audited by Deloitte Haskins & Sells LLP. It is one of the largest big4 accounting firm networks headquartered in England. They have been auditing the financials of the group from the financial year ending March 2017.

Market Capitalisation and Stock Information

Apollo Enterprise Ltd., went public in the year 1979. Consequently, it was listed in the NSE in January 1996, followed by BSE and several other exchanges. Since then, the stock has performed well and even stood out as the top performer in its peer groups in recent times. Let's look at some of the facts and figures:

●   The TTQ or Total Traded Quantity of its stock is 0.18 Lakhs.
●  The Face Value of shares is INR 5 each.
●  The stock is part of the S&P BSE 100 Index.

Shareholding Pattern

Out of the total stake, FIIs held 50.81%, Other Domestic Institutions 6.51%, Mutual Funds 5.94%, and Retail and Other investors held 7.41% of the company's equity shares.

The top mutual funds that have invested more than 2% of their AUM in the stock are Nippon India Pharma Fund, IDFC Balanced Advantage Fund, LIC MF Large Cap Fund and Sundaram Services Fund.

Corporate Social Responsibility Information

Steered by Dr Reddy, the founder and chairman of the group Apollo has been an exemplar in philanthropic collaborations and endeavours. The group's Total Health Cycle philosophy is: to 'screen, diagnose, treat, educate, and empower.' It successfully runs 3 philanthropic and humanitarian programs that aim at the economic and social prosperity of the underprivileged.

Total Health Program

This CSR model aims to enhance the mental, physical, social, ecological and spiritual health of individuals and the community at large. It directs its activities toward the society's comprehensive welfare and is mostly concentrated in the rural areas of Andhra Pradesh and Telangana.

Billion Hearts Beating Foundation

This non-profit organisation which runs several charitable projects for the elderly, public servants and healthcare workers, contributes by way of medicine supply and organisation of free healthcare camps for the beneficiaries. It also operates some critical care units in areas of public interest.

The SACHi Initiative

SACHi, on the other hand, is a child-focused non-profit initiative that fights for causes such as equal rights and quality healthcare for children. Over the years, it has provided free heart treatments, medicines and supplements to numerous children's homes and orphanages. It continues to pledge its services to touch the lives of many more children in the times to come.

Financial Information

Top Line

Over the last 5 years, the audited financial statements show a leap of INR 6420 crores in the Apollo group's total revenue. The revenue can be segregated as - 56% from core healthcare services and 9% from Apollo Health and Lifestyle, including Clinics, Diagnostic Centres, Dental, Dialysis and Fertility centres. Another 35% comes from the Pharmacy Distribution.

Bottom Line

On the other hand, the profit recorded has grown exponentially from Rs. 117 crores by a whopping 802.5% over the course of 5 years. The highest growth can be seen in the financial year 2021-22, when the bottom line grew 10 times. This can be attributed to a significant increase in revenue with a reduction in selling, general and administrative expenses.

 

 

View More
  • NSE Symbol
  • APOLLOHOSP
  • BSE Symbol
  • 508869
  • Managing Director
  • Mrs. Suneeta Reddy
  • ISIN
  • INE437A01024

Similar Stocks to Apollo Hospitals Enterprise

Apollo Hospitals Enterprise FAQs

Apollo Hospitals Enterprise share price is ₹6,720 As on 21 November, 2024 | 14:07

The Market Cap of Apollo Hospitals Enterprise is ₹96632.7 Cr As on 21 November, 2024 | 14:07

The P/E ratio of Apollo Hospitals Enterprise is 81.7 As on 21 November, 2024 | 14:07

The PB ratio of Apollo Hospitals Enterprise is 13.2 As on 21 November, 2024 | 14:07

The ROE of Apollo Hospitals Enterprise is 3% which is fair but needs improvement.

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned as the architect of modern healthcare in India.

The stock price CAGR of Apollo Hospitals Enterprise for 10 Years is 23%, 5 Years is 33%, 3 Years is 55%, 1 Year is 98%.

Apollo Hospital Enterprise has an operating revenue of Rs. 13,105.07 Cr. on a trailing 12-month basis. Annual revenue de-growth of -6% needs improvement, Pre-tax margin of 2% needs improvement. The company has a debt to equity of 54%, which is a bit higher. Several analysts have a Buy rating on the stock.

You can easily buy the shares of Apollo Hospitals Enterprise Ltd., by registering with 5paisa and opening a demat account. You can also register via the 5paisa mobile app.
 

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23